The cookie settings on this website are set to 'allow all cookies' to give you the very best experience. Please click Accept Cookies to continue to use the site.

Our Story


About FlutiCare®

FlutiCare®is a nasal spray, which provides 50 micrograms of fluticasone propionate (“USP”) per spray, a nasal corticosteroid that provides 24-hour temporary relief of seasonal and perennial nasal allergy symptoms. FlutiCare® can be used to relieve both indoor and outdoor nasal allergy symptoms caused by pollen, dust, animal dander, and other indoor and outdoor allergens. Nasal allergy symptoms include, nasal congestion, runny nose, sneezing, itchy nose, etc.

FlutiCare® contains the nasal steroid API that is physician recommended and consumer preferred.

    • #1 form used by patients
    • #1 nasal steroid active prescribed by physicians
    • Familiar to patients, comfort of a known & trusted medicine
    • Engrained in patients’ allergy management
    • Effective and safe

FlutiCare® is available in over 10,000 independent pharmacies, direct and through Amerisource Bergen and McKesson, through via its Beyond Human® print media platform and through its extensive online channels and distributors, including, and

FlutiCare® was approved by the U.S. Food and Drug Administration (“FDA”) for OTC availability through its partner’s approved abbreviated new drug application (“ANDA”) No. 207957. FlutiCare® allergy relief joins the growing Innovus Pharma product family, offering a burgeoning portfolio of non-prescription medicine and consumer care supplements to consumers.

FlutiCare® becomes the Company’s second available allergy relief product along with AllerVarx®, a patented dietary supplement formulated to provide relief during the allergy season, already on the market.